Name:
"Coprococcus sp."
DSM No.:
107472
Strain designation:
E50
Isolated from:
human faeces
Country:
Canada
Calgary
Date of sampling:
01.01.2014
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; E50
Cultivation conditions:
Medium 110a , 37°C
or
Medium 1611 , 37°C
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; E50. Human faeces; Canada, Calgary. Taxonomy/description (30548). (Medium 110a or Medium 1611, 37°C, anaerobic).
Literature:
30548
Risk group:
1 (provisional classification by DSMZ)
"Coprococcus sp."
DSM No.:
107472
Strain designation:
E50
Isolated from:
human faeces
Country:
Canada
Calgary
Date of sampling:
01.01.2014
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; E50
Cultivation conditions:
Medium 110a , 37°C
or
Medium 1611 , 37°C
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List
Summary and
additional information:
<- H. Browne, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; E50. Human faeces; Canada, Calgary. Taxonomy/description (30548). (Medium 110a or Medium 1611, 37°C, anaerobic).
Literature:
30548
Risk group:
1 (provisional classification by DSMZ)
DSM107472
